Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1638 1656 1799
This examiner grants 65% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18304472 | GENE THERAPEUTICS FOR FIBRODYSPLASIA OSSIFICANS PROGRESSIVA | Final Rejection | University of Massachusetts |
| 18683697 | TREATING CANCER | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 18546221 | METHODS FOR PREPARATION OF PLASMID DNA/LIPID PARTICLES WITH DEFINED SIZE FOR IN VITRO AND IN VIVO TRANSFECTION | Non-Final OA | The Johns Hopkins University |
| 18657020 | SYSTEMS AND METHOD FOR PRODUCING T-CELLS | Non-Final OA | Terumo BCT, Inc. |
| 18711287 | RNA SEQUENCES THAT INDUCE FLUORESCENCE OF SMALL MOLECULE FLUOROPHORES, MOLECULAR COMPLEXES, SENSORS, AND METHODS OF USE THEREOF | Non-Final OA | CORNELL UNIVERSITY |
| 18695720 | METHOD FOR PRODUCING T CELL | Non-Final OA | TAKEDA PHARMACEUTICAL COMPANY LIMITED |
| 18800672 | NOVEL RAPID DRUG DISCOVERY FOR SEPSIS AND AGENTS FOR USE AS SEPSIS THERAPY | Non-Final OA | THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY |
| 18552165 | Optimized Nucleotide Sequences Encoding the Extracellular Domain of Human ACE2 Protein or a Portion Thereof | Non-Final OA | TRANSLATE BIO, INC. |
| 18376459 | METHOD FOR PREPARING COMPOSITION COMPRISING MESENCHYMAL STEM CELL, EXTRACELLULAR VESICLE PRODUCED BY MESENCHYMAL STEM CELL, AND GROWTH FACTOR, COMPOSITION PREPARED BY THE METHOD, AND USE OF COMPOSITION FOR TREATING ARTHRITIS | Final Rejection | GWO XI STEM CELL APPLIED TECHNOLOGY CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy